T
TSHA
Taysha Gene Therapies, Inc.
4.370
+0.060+1.39%After Hours: 4.440 +0.070 +1.60%18:30 04/02 EDT
OPEN/PREV CLOSE4.750/4.570
TODAY RANGE4.440-4.780
VOL2.31M
MARKET CAP1.31B
52 WEEK RANGE1.050-6.02
AVG VOL (3M)2.70M
% TURNOVER0.81%
TURNOVER--
P/E (TTM)-13.3470
% RANGE7.44%
EPS(TTM)-0.3409
P/E(FORWARD)-11.3750
P/B5.25
BVPS0.8663
DIVIDEND--
P/S132.65
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.16B
SHARES OUTSTANDING287.27M
NEXT EARNINGS05/13-05/18
FREE FLOAT255.63M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·2d ago
Taysha Gene Therapies Is Maintained at Buy by Canaccord Genuity
Simply Wall St·6d ago
Is Taysha (TSHA) Recasting Its Rett Strategy With New Market Access Hire After Wider Losses?
TipRanks·03/25 12:18
Taysha Gene Therapies (TSHA) Receives a Buy from Cantor Fitzgerald
Simply Wall St·03/22 21:08
Should Rett Breakthrough Status and Pivotal Trial Progress Require Action From Taysha Gene Therapies (TSHA) Investors?
TipRanks·03/22 13:15
Taysha Gene Therapies (TSHA) Receives a Buy from Wells Fargo
Simply Wall St·03/21 19:09
Taysha Gene Therapies Advances Rett Program As Valuation Draws Investor Focus
TipRanks·03/20 13:26
Jefferies Reaffirms Their Buy Rating on Taysha Gene Therapies (TSHA)
Same Industry
Name/Symbol
Change%
Price